Loading...
Header Logo
Keywords
Last Name
Institution

ANN H KLOPP

TitleAssociate Professor
InstitutionMD Anderson
DepartmentRadiation Oncology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Beriwal S, Lee LJ, Chino JP, Albuquerque K, Klopp AH. Scores and Misses With New Technology-Walking the Narrow Path of Evidence. Int J Radiat Oncol Biol Phys. 2019 Oct 01; 105(2):237-241. PMID: 31492378.
      View in: PubMed
    2. Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G. Pelvic insufficiency fractures after external beam radiotherapy for gynecologic cancers: a meta-analysis and meta-regression of 3,929 patients. Int J Radiat Oncol Biol Phys. 2019 Sep 30. PMID: 31580930.
      View in: PubMed
    3. Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019 Sep 06. PMID: 31500892.
      View in: PubMed
    4. Venkatesan AM, Menias CO, Jones KM, Rauch GM, Stafford RJ, Klopp AH. MRI for Radiation Therapy Planning in Human Papillomavirus-associated Gynecologic Cancers. Radiographics. 2019 Sep-Oct; 39(5):1476-1500. PMID: 31498740.
      View in: PubMed
    5. Netherton T, Li Y, Gao S, Klopp A, Balter P, Court LE, Scheuermann R, Kennedy C, Dong L, Metz J, Mihailidis D, Ling C, Young Lee M, Constantin M, Thompson S, Kauppinen J, Uusitalo P. Experience in commissioning the halcyon linac. Med Phys. 2019 Oct; 46(10):4304-4313. PMID: 31310678.
      View in: PubMed
    6. Coletta AM, Klopp AH, Fogelman D, Parikh AM, Li Y, Garg N, Basen-Engquist K. Dual-Energy X-Ray Absorptiometry Compared to Computed Tomography for Visceral Adiposity Assessment Among Gastrointestinal and Pancreatic Cancer Survivors. Sci Rep. 2019 Aug 08; 9(1):11500. PMID: 31395928.
      View in: PubMed
    7. Lu DJ, Luu M, Yashar CM, Klopp AH, Kamrava M. An evaluation of gender diversity in the American Brachytherapy Society. Brachytherapy. 2019 Aug 08. PMID: 31402211.
      View in: PubMed
    8. Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G. Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy. 2019 Sep - Oct; 18(5):620-626. PMID: 31160198.
      View in: PubMed
    9. Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol. 2019 07; 154(1):22-28. PMID: 31109659.
      View in: PubMed
    10. Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol. 2019 07; 154(1):183-188. PMID: 31104905.
      View in: PubMed
    11. Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy. 2019 Jul - Aug; 18(4):445-452. PMID: 30992185.
      View in: PubMed
    12. Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol. 2019 Jun; 135:58-64. PMID: 31015171.
      View in: PubMed
    13. Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol. 2019 03; 152(3):439-444. PMID: 30876486.
      View in: PubMed
    14. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2019 03; 152(3):540-547. PMID: 30665615.
      View in: PubMed
    15. Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 Mar - Apr; 18(2):123-132. PMID: 30665713.
      View in: PubMed
    16. Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND. Prognostic factors impacting survival in early stage uterine carcinosarcoma. Gynecol Oncol. 2019 01; 152(1):31-37. PMID: 30414738.
      View in: PubMed
    17. Eifel PJ, Klopp AH. In reply to Keenan et al. Anatomic principles as the basis of target volume definition. Radiother Oncol. 2019 Jul; 136:198-199. PMID: 30279048.
      View in: PubMed
    18. Li Y, Netherton T, Nitsch PL, Gao S, Klopp AH, Balter PA, Court LE. Independent validation of machine performance check for the Halcyon and TrueBeam linacs for daily quality assurance. J Appl Clin Med Phys. 2018 Sep; 19(5):375-382. PMID: 30016578.
      View in: PubMed
    19. Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A. Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):593-600. PMID: 30017792.
      View in: PubMed
    20. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018 08 20; 36(24):2538-2544. PMID: 29989857.
      View in: PubMed
    21. Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM. Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment. Int J Radiat Oncol Biol Phys. 2018 08 01; 101(5):1046-1056. PMID: 30012524.
      View in: PubMed
    22. Li Y, Netherton T, Nitsch PL, Balter PA, Gao S, Klopp AH, Court LE. Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT. J Appl Clin Med Phys. 2018 May; 19(3):52-57. PMID: 29500856.
      View in: PubMed
    23. Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH. Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer. Int J Gynecol Cancer. 2018 02; 28(2):285-292. PMID: 29303933.
      View in: PubMed
    24. Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018 03; 148(3):474-479. PMID: 29336837.
      View in: PubMed
    25. Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH. Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma. Int J Gynecol Cancer. 2018 01; 28(1):114-121. PMID: 28930812.
      View in: PubMed
    26. Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol. 2018 01; 148(1):132-138. PMID: 29089122.
      View in: PubMed
    27. Parikh AM, Coletta AM, Yu ZH, Rauch GM, Cheung JP, Court LE, Klopp AH. Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images. PLoS One. 2017; 12(8):e0183515. PMID: 28859115.
      View in: PubMed
    28. Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN. Factors prognostic of survival in advanced-stage uterine serous carcinoma. Gynecol Oncol. 2017 07; 146(1):27-33. PMID: 28465008.
      View in: PubMed
    29. Swanick CW, Eifel PJ, Klopp AH. In Reply to Mazeron et al. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):639. PMID: 28126311.
      View in: PubMed
    30. Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys. 2017 03 01; 97(3):546-553. PMID: 28011045.
      View in: PubMed
    31. Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecol Oncol. 2016 Dec; 143(3):552-557. PMID: 27645621.
      View in: PubMed
    32. Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Pract Radiat Oncol. 2017 May - Jun; 7(3):e165-e173. PMID: 27743802.
      View in: PubMed
    33. Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):793-800. PMID: 27788952.
      View in: PubMed
    34. Jhingran A, Klopp A. Big Data to the Rescue: Is there a benefit to combined-modality adjuvant therapy in endometrial cancer? Gynecol Oncol. 2016 06; 141(3):403-404. PMID: 27210265.
      View in: PubMed
    35. Fleming ND, Soliman PT, Westin SN, dos Reis R, Munsell M, Klopp AH, Frumovitz M, Nick AM, Schmeler K, Ramirez PT. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer. Int J Gynecol Cancer. 2015 Oct; 25(8):1437-44. PMID: 26332387.
      View in: PubMed
    36. Mitra D, Klopp AH, Viswanathan AN. Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer. Gynecol Oncol. 2016 Jan; 140(1):167-75. PMID: 26432041.
      View in: PubMed
    37. Grant SR, Walker GV, Koshy M, Shaitelman SF, Klopp AH, Frank SJ, Pugh TJ, Allen PK, Mahmood U. Impact of Insurance Status on Radiation Treatment Modality Selection Among Potential Candidates for Prostate, Breast, or Gynecologic Brachytherapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):968-75. PMID: 26452570.
      View in: PubMed
    38. Zhang Y, Nowicka A, Solley TN, Wei C, Parikh A, Court L, Burks JK, Andreeff M, Woodward WA, Dadbin A, Kolonin MG, Lu KH, Klopp AH. Stromal Cells Derived from Visceral and Obese Adipose Tissue Promote Growth of Ovarian Cancers. PLoS One. 2015; 10(8):e0136361. PMID: 26317219.
      View in: PubMed
    39. Ho JC, Allen PK, Jhingran A, Westin SN, Lu KH, Eifel PJ, Klopp AH. Management of nodal recurrences of endometrial cancer with IMRT. Gynecol Oncol. 2015 Oct; 139(1):40-6. PMID: 26193429.
      View in: PubMed
    40. Schwarz JK, Beriwal S, Esthappan J, Erickson B, Feltmate C, Fyles A, Gaffney D, Jones E, Klopp A, Small W, Thomadsen B, Yashar C, Viswanathan A. Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer. Brachytherapy. 2015 Sep-Oct; 14(5):587-99. PMID: 26186975.
      View in: PubMed
    41. Grant JD, Garg AK, Gopal R, Soliman PT, Jhingran A, Eifel PJ, Klopp AH. Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy. Int J Gynecol Cancer. 2015 Jun; 25(5):869-74. PMID: 25790043.
      View in: PubMed
    42. Gardner CS, Sunil J, Klopp AH, Devine CE, Sagebiel T, Viswanathan C, Bhosale PR. Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol. 2015 Aug; 88(1052):20150033. PMID: 25966291.
      View in: PubMed
    43. Yashar C, Beriwal S, Mell L, Klopp A. A blast from the past and foresight for the future of gynecologic oncology. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):885-7. PMID: 25832680.
      View in: PubMed
    44. Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Res. 2015 Mar 20; 17:42. PMID: 25887413.
      View in: PubMed
    45. Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy. 2015 May-Jun; 14(3):385-9. PMID: 25620163.
      View in: PubMed
    46. Thaker NG, Klopp AH, Jhingran A, Frumovitz M, Iyer RB, Eifel PJ. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73. PMID: 25524458.
      View in: PubMed
    47. Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler KM, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014 Dec; 124(6):1098-104. PMID: 25415160.
      View in: PubMed
    48. Salimian Rizi B, Caneba C, Nowicka A, Nabiyar AW, Liu X, Chen K, Klopp A, Nagrath D. Nitric oxide mediates metabolic coupling of omentum-derived adipose stroma to ovarian and endometrial cancer cells. Cancer Res. 2015 Jan 15; 75(2):456-71. PMID: 25425006.
      View in: PubMed
    49. Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, Schmeler KM, Klopp AH, Fleming ND. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol. 2014 Dec; 135(3):455-61. PMID: 25449308.
      View in: PubMed
    50. Bishop AJ, Allen PK, Klopp AH, Meyer LA, Eifel PJ. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int J Radiat Oncol Biol Phys. 2015 Jan 01; 91(1):196-205. PMID: 25446609.
      View in: PubMed
    51. Rauch GM, Kaur H, Choi H, Ernst RD, Klopp AH, Boonsirikamchai P, Westin SN, Marcal LP. Optimization of MR imaging for pretreatment evaluation of patients with endometrial and cervical cancer. Radiographics. 2014 Jul-Aug; 34(4):1082-98. PMID: 25019443.
      View in: PubMed
    52. Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W, Yashar C, Viswanathan AN. The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014 May-Jun; 4(3):137-144. PMID: 24766678.
      View in: PubMed
    53. Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):357-62. PMID: 24411609.
      View in: PubMed
    54. Nowicka A, Marini FC, Solley TN, Elizondo PB, Zhang Y, Sharp HJ, Broaddus R, Kolonin M, Mok SC, Thompson MS, Woodward WA, Lu K, Salimian B, Nagrath D, Klopp AH. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One. 2013; 8(12):e81859. PMID: 24312594.
      View in: PubMed
    55. Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy. 2014 May-Jun; 13(3):240-9. PMID: 24188993.
      View in: PubMed
    56. Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Beadle BM. Clinical characteristics of patients with multiple potentially human papillomavirus-related malignancies. Head Neck. 2014 Jun; 36(6):819-25. PMID: 23720126.
      View in: PubMed
    57. Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One. 2013; 8(8):e71508. PMID: 24013655.
      View in: PubMed
    58. Mikell JK, Klopp AH, Price M, Mourtada F. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats. Brachytherapy. 2013 Nov-Dec; 12(6):645-53. PMID: 23891341.
      View in: PubMed
    59. Spaeth EL, Labaff AM, Toole BP, Klopp A, Andreeff M, Marini FC. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res. 2013 Sep 01; 73(17):5347-59. PMID: 23838935.
      View in: PubMed
    60. Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):300-5. PMID: 23648467.
      View in: PubMed
    61. Klopp AH, Moughan J, Portelance L, Miller BE, Salehpour MR, Hildebrandt E, Nuanjing J, D'Souza D, Souhami L, Small W, Gaur R, Jhingran A. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):83-90. PMID: 23582248.
      View in: PubMed
    62. Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol. 2013 Dec; 131(3):645-9. PMID: 23643871.
      View in: PubMed
    63. Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50. PMID: 23332221.
      View in: PubMed
    64. Frumovitz M, Ramirez PT, Macapinlac HA, Klopp AH, Nick AM, Ramondetta LM, Jhingran A. Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging. Int J Gynecol Cancer. 2012 Sep; 22(7):1203-7. PMID: 22810967.
      View in: PubMed
    65. Klopp AH, Mourtada F, Yu ZH, Beadle BM, Munsell MF, Jhingran A, Eifel PJ. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Pract Radiat Oncol. 2013 Apr-Jun; 3(2):115-23. PMID: 24674314.
      View in: PubMed
    66. Shirvani SM, Klopp AH, Likhacheva A, Jhingran A, Soliman PT, Lu KH, Eifel PJ. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):e21-e28. PMID: 24674269.
      View in: PubMed
    67. Klopp AH, Eifel PJ. Biological predictors of cervical cancer response to radiation therapy. Semin Radiat Oncol. 2012 Apr; 22(2):143-50. PMID: 22385921.
      View in: PubMed
    68. Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):45-53. PMID: 24674263.
      View in: PubMed
    69. Mikell JK, Klopp AH, Gonzalez GM, Kisling KD, Price MJ, Berner PA, Eifel PJ, Mourtada F. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e417-22. PMID: 22436788.
      View in: PubMed
    70. Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One. 2012; 7(2):e30563. PMID: 22363446.
      View in: PubMed
    71. Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, Debeb B, Woodward W, Schmandt R, Broaddus R, Lu K, Kolonin MG. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res. 2012 Feb 01; 18(3):771-82. PMID: 22167410.
      View in: PubMed
    72. Klopp AH, Eifel PJ. Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep. 2011 Feb; 13(1):77-85. PMID: 21042887.
      View in: PubMed
    73. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells. 2011 Jan; 29(1):11-9. PMID: 21280155.
      View in: PubMed
    74. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim. 2011; 36(4):383-8. PMID: 21144734.
      View in: PubMed
    75. Clements A, Euscher E, Lacour R, Merritt W, Klopp A, Ramondetta L. The presence of human papillomavirus or p16 in six cases of retroperitoneal carcinoma. Obstet Gynecol. 2010 Nov; 116(5):1042-6. PMID: 20966687.
      View in: PubMed
    76. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, Li L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One. 2010 Aug 16; 5(8):e12180. PMID: 20808935.
      View in: PubMed
    77. Garg AK, Jhingran A, Klopp AH, Aggarwal BB, Kunnumakkara AB, Broadus RR, Eifel PJ, Buchholz TA. Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1331-6. PMID: 20231067.
      View in: PubMed
    78. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 2009 Oct; 27(10):2614-23. PMID: 19650040.
      View in: PubMed
    79. Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation. Gynecol Oncol. 2009 Oct; 115(1):6-11. PMID: 19632709.
      View in: PubMed
    80. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 2009; 4(4):e4992. PMID: 19352430.
      View in: PubMed
    81. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol. 2009 Jan 30; 4:5. PMID: 19183471.
      View in: PubMed
    82. Klopp AH, Jhingran A, Ramdas L, Story MD, Broadus RR, Lu KH, Eifel PJ, Buchholz TA. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):226-36. PMID: 18406887.
      View in: PubMed
    83. Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008 May; 15(10):730-8. PMID: 18401438.
      View in: PubMed
    84. Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC. The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy. 2008; 10(7):657-67. PMID: 18985472.
      View in: PubMed
    85. Klopp AH, Spaeth EL, Dembinski JL, Woodward WA, Munshi A, Meyn RE, Cox JD, Andreeff M, Marini FC. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 2007 Dec 15; 67(24):11687-95. PMID: 18089798.
      View in: PubMed
    86. Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1409-16. PMID: 17904303.
      View in: PubMed
    87. Klopp AH, Eapen GA, Komaki RR. Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction. Clin Lung Cancer. 2006 Nov; 8(3):203-7. PMID: 17239296.
      View in: PubMed
    88. Klopp AH, Eifel PJ. Gene expression profiling in cervical cancer: state of the art and future directions. Cancer J. 2006 May-Jun; 12(3):170-4. PMID: 16803672.
      View in: PubMed
    89. Hoge AT, Hendrickson SB, Burns WH. Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J Virol. 2000 Aug; 74(15):7016-23. PMID: 10888640.
      View in: PubMed
    90. Glover TW, Hoge AW, Miller DE, Ascara-Wilke JE, Adam AN, Dagenais SL, Wilke CM, Dierick HA, Beer DG. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Cancer Res. 1998 Aug 01; 58(15):3409-14. PMID: 9699673.
      View in: PubMed
    91. Mesirow KM, Klopp A, Olson LL. Improving certified nurse aide retention. A long-term care management challenge. J Nurs Adm. 1998 Mar; 28(3):56-61. PMID: 9524551.
      View in: PubMed
    92. Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge A, Glover TW, Smith DI. A 350-kb cosmid contig in 3p14.2 that crosses the t(3;8) hereditary renal cell carcinoma translocation breakpoint and 17 aphidicolin-induced FRA3B breakpoints. Genomics. 1996 Jul 01; 35(1):87-93. PMID: 8661108.
      View in: PubMed
    93. Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet. 1996 Feb; 5(2):187-95. PMID: 8824874.
      View in: PubMed
    94. Klopp A. The ET nurse as researcher: governing our practice. J Enterostomal Ther. 1986 Nov-Dec; 13(6):232-4. PMID: 3640778.
      View in: PubMed
    95. Schindler R, Klopp A. Transport of esterified retinol in fasting human blood. Int J Vitam Nutr Res. 1986; 56(1):21-7. PMID: 3710714.
      View in: PubMed
    96. Schindler R, Klopp A, Gorny C, Feldheim W. Comparison between three fluorometric micromethods for determination of vitamin A in serum. Int J Vitam Nutr Res. 1985; 55(1):25-34. PMID: 3997395.
      View in: PubMed
    97. Klopp A. Clarification on 'shunting malignant ascites'. Am J Nurs. 1984 Oct; 84(10):1208. PMID: 6567446.
      View in: PubMed
    98. Klopp A. Considering alternatives: a form of adaptation. J Enterostomal Ther. 1984 Mar-Apr; 11(2):49. PMID: 6561204.
      View in: PubMed
    99. Klopp A. Shunting malignant ascites. Am J Nurs. 1984 Feb; 84(2):212-3. PMID: 6559539.
      View in: PubMed
    100. Klopp A. Specialty practice and generic goals: a case for collaboration. J Enterostomal Ther. 1984 Jan-Feb; 11(1):19-21. PMID: 6559824.
      View in: PubMed
    101. Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma. International Journal of Radiation Oncology Biology Physics.
    102. Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer. International Journal of Gynecological Cancer. 25:869-874.
    103. Node-positive adenocarcinoma of the endometrium. Obstetrical and Gynecological Survey. 64:798-800.
    104. A blast from the past and foresight for the future of gynecologic oncology. International Journal of Radiation Oncology Biology Physics. 91:885-887.
    105. Stromal cells derived from visceral and obese adipose tissue promote growth of ovarian cancers. PLoS One. 10.
    106. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy. Practical Radiation Oncology.
    107. Anatomic distribution of [18F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Practical Radiation Oncology. 3:45-53.
    108. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Research. 17.
    109. Pilot study of a computed tomography-compatible shielded intracavitary brachytherapy applicator for treatment of cervical cancer. Practical Radiation Oncology. 3:115-123.
    110. Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. Practical Radiation Oncology. 3.
    111. International Journal of Radiation Oncology Biology Physics. 96:793-800.
    112. Correction. PLoS One. 8.
    113. Impact of lymph node ratio and adjuvant therapy in node-positive endometrioid endometrial cancer. International Journal of Gynecological Cancer. 25:1437-1444.
    114. Patterns of recurrence and survival in neuroendocrine cervical cancer. Gynecologic Oncology. 143:552-557.
    115. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. International Journal of Radiation Oncology Biology Physics. 97:546-553.
    116. Adjuvant vaginal brachytherapy for early-stage endometrial cancer. Brachytherapy.
    117. Increased adiposity and endometrial cancer risk. 53-69.
    118. Cancer of the cervix, vagina, and vulva.
    119. Field cancerization in vulvar, vaginal and cervical epithelia. 415-422.
    KLOPP's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description